Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

about

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

Item

http://www.wikidata.org/entity/Q47105115

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

@en

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

@nl

type

Item

label

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

@en

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

@nl

prefLabel

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

@en

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

@nl

P1476

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.

@en

P2093

Catherine King

http://www.w3.org/2001/XMLSchema#string

Lorraine Harper

http://www.w3.org/2001/XMLSchema#string

P2860

Nystatin prophylaxis and treatment in severely immunodepressed patients

Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa

Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide.

UK clinical guideline for the prevention and treatment of osteoporosis

Calcium and vitamin D for corticosteroid-induced osteoporosis.

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.

Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis

Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.

P2888

s40674-017-0082-y

P304

230-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40674-017-0082-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29201630

http://www.w3.org/2001/XMLSchema#string

P932

5694500

http://www.w3.org/2001/XMLSchema#string